Accumulation of natriuretic peptides is associated with protein energy wasting and activation of browning in white adipose tissue in chronic kidney disease.


Journal

Kidney international
ISSN: 1523-1755
Titre abrégé: Kidney Int
Pays: United States
ID NLM: 0323470

Informations de publication

Date de publication:
09 2020
Historique:
received: 21 03 2019
revised: 26 02 2020
accepted: 09 03 2020
pubmed: 3 8 2020
medline: 22 6 2021
entrez: 3 8 2020
Statut: ppublish

Résumé

Protein energy wasting is a common feature of patients with chronic kidney disease (CKD) and is associated with poor outcomes. Protein energy wasting and cachexia, a severe form of protein energy wasting, are characterized by increased resting energy expenditure but the underlying mechanisms are unclear. Browning corresponds to the activation of inducible brown adipocytes in white adipose tissue and occurs in states of cachexia associated with hypermetabolic disease such as cancer. Here we tested the hypothesis that CKD-associated protein energy wasting could result from browning activation as a direct effect of the uremic environment on adipocytes. In a murine model of CKD (5/6 nephrectomy), there was increased resting energy expenditure, expression of uncoupling protein 1 (a thermogenic protein uncoupling oxidative phosphorylation in mitochondria) and citrate synthase activity (a proxy of mitochondrial density in white adipose tissue). Mice with CKD also exhibited increased levels of atrial natriuretic peptide, a well known activator of browning. The incubation of primary adipose cells with plasma from patients receiving dialysis treatment and having signs of protein energy wasting led to an increased synthesis of uncoupling protein 1. Similarly, primary adipose cells exposed to atrial natriuretic peptide at concentrations relevant of CKD led to a significant increase of uncoupling protein 1 content. Thus, accumulation of cardiac natriuretic peptides during CKD could contribute to the browning of white adipose tissue and protein energy wasting.

Identifiants

pubmed: 32739210
pii: S0085-2538(20)30407-5
doi: 10.1016/j.kint.2020.03.027
pii:
doi:

Substances chimiques

Natriuretic Peptides 0
Uncoupling Protein 1 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

663-672

Informations de copyright

Copyright © 2020 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Auteurs

Mathilde Luce (M)

Department of Nephrology, Civil Hospices of Lyon, Lyon Sud Hospital Center, Pierre Benite, France; University of Lyon, CarMeN lab, National Institute of Applied Sciences of Lyon (INSA-Lyon), French National Institute of Health and Medical Research (INSERM) U1060, National Institute of Agricultural Research (INRA), Claude Bernard University Lyon 1, Villeurbanne, France.

Christophe Barba (C)

Department of Nephrology, Civil Hospices of Lyon, Lyon Sud Hospital Center, Pierre Benite, France; University of Lyon, CarMeN lab, National Institute of Applied Sciences of Lyon (INSA-Lyon), French National Institute of Health and Medical Research (INSERM) U1060, National Institute of Agricultural Research (INRA), Claude Bernard University Lyon 1, Villeurbanne, France.

Dan Yi (D)

Department of Nephrology, Civil Hospices of Lyon, Lyon Sud Hospital Center, Pierre Benite, France.

Anne Mey (A)

University of Lyon, CarMeN lab, National Institute of Applied Sciences of Lyon (INSA-Lyon), French National Institute of Health and Medical Research (INSERM) U1060, National Institute of Agricultural Research (INRA), Claude Bernard University Lyon 1, Villeurbanne, France.

Damien Roussel (D)

Natural and Anthropic Hydrosystems Ecology Laboratory, University of Lyon, Claude Bernard Lyon University 1, National School of Public Works of the State (ENTPE), Villeurbanne, France.

Emilie Bres (E)

Department of Nephrology, Civil Hospices of Lyon, Lyon Sud Hospital Center, Pierre Benite, France; University of Lyon, CarMeN lab, National Institute of Applied Sciences of Lyon (INSA-Lyon), French National Institute of Health and Medical Research (INSERM) U1060, National Institute of Agricultural Research (INRA), Claude Bernard University Lyon 1, Villeurbanne, France.

Bérengère Benoit (B)

University of Lyon, CarMeN lab, National Institute of Applied Sciences of Lyon (INSA-Lyon), French National Institute of Health and Medical Research (INSERM) U1060, National Institute of Agricultural Research (INRA), Claude Bernard University Lyon 1, Villeurbanne, France.

Myriam Pastural (M)

Association pour l'Utilisation du Rein Artificiel dans la région Lyonnaise (AURAL), Lyon, France.

Samuel Granjon (S)

Laboratoire d'Analyse Médicale Cerballiance Rhône alpes, Lyon, France.

Jean Christophe Szelag (JC)

Association pour l'Utilisation du Rein Artificiel dans la région Lyonnaise (AURAL), Lyon, France.

Maurice Laville (M)

Department of Nephrology, Civil Hospices of Lyon, Lyon Sud Hospital Center, Pierre Benite, France.

Walid Arkouche (W)

Association pour l'Utilisation du Rein Artificiel dans la région Lyonnaise (AURAL), Lyon, France.

Anais Bouchara (A)

Department of Nephrology, Civil Hospices of Lyon, Lyon Sud Hospital Center, Pierre Benite, France.

Elsa Nyam (E)

Montreal Diabetes Research Center, CRCHUM, Montréal, Quebec, Canada; Department of Medicine, University of Montreal, Montreal, Quebec, Canada.

Denis Fouque (D)

Department of Nephrology, Civil Hospices of Lyon, Lyon Sud Hospital Center, Pierre Benite, France; University of Lyon, CarMeN lab, National Institute of Applied Sciences of Lyon (INSA-Lyon), French National Institute of Health and Medical Research (INSERM) U1060, National Institute of Agricultural Research (INRA), Claude Bernard University Lyon 1, Villeurbanne, France.

Christophe O Soulage (CO)

University of Lyon, CarMeN lab, National Institute of Applied Sciences of Lyon (INSA-Lyon), French National Institute of Health and Medical Research (INSERM) U1060, National Institute of Agricultural Research (INRA), Claude Bernard University Lyon 1, Villeurbanne, France.

Laetitia Koppe (L)

Department of Nephrology, Civil Hospices of Lyon, Lyon Sud Hospital Center, Pierre Benite, France; University of Lyon, CarMeN lab, National Institute of Applied Sciences of Lyon (INSA-Lyon), French National Institute of Health and Medical Research (INSERM) U1060, National Institute of Agricultural Research (INRA), Claude Bernard University Lyon 1, Villeurbanne, France. Electronic address: Laetitia.koppe@chu-lyon.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH